Your browser doesn't support javascript.
loading
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.
Gennari, A; André, F; Barrios, C H; Cortés, J; de Azambuja, E; DeMichele, A; Dent, R; Fenlon, D; Gligorov, J; Hurvitz, S A; Im, S-A; Krug, D; Kunz, W G; Loi, S; Penault-Llorca, F; Ricke, J; Robson, M; Rugo, H S; Saura, C; Schmid, P; Singer, C F; Spanic, T; Tolaney, S M; Turner, N C; Curigliano, G; Loibl, S; Paluch-Shimon, S; Harbeck, N.
Affiliation
  • Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • André F; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif, France.
  • Barrios CH; Oncology Research Center, Grupo Oncoclínicas, Porto Alegre, Brazil.
  • Cortés J; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain; Scientific Department, Medica Scientia Innovation Research, Valencia, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Departm
  • de Azambuja E; Medical Oncology Department, Institute Jules Bordet and l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • DeMichele A; Hematology/Oncology Department, Hospital of the University of Pennsylvania, Philadelphia, USA.
  • Dent R; Department of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Fenlon D; College of Human and Health Sciences, Swansea University-Singleton Park Campus, Swansea, UK.
  • Gligorov J; Départment d' Oncologie Médicale, Institut Universitaire de Cancérologie AP-HP, Sorbonne Université, Hôpital Tenon, Paris, France.
  • Hurvitz SA; Department of Medicine/Division of Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles, USA; Jonsson Comprehensive Cancer Center, Los Angeles, USA.
  • Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Krug D; Department of Radiation Oncology, University Hospital Schleswig-Holstein-Campus Kiel, Kiely, Germany.
  • Kunz WG; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Penault-Llorca F; Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR INSERM-UCA, Clermont Ferrand, France.
  • Ricke J; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif, France; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Robson M; Medicine Department, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Rugo HS; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
  • Saura C; Breast Cancer Program, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Schmid P; Centre of Experimental Cancer Medicine, Cancer Research UK Barts Centre, Barts and The London School of Medicine and Dentistry, London, UK.
  • Singer CF; Center for Breast Health and Department of Obstetrics & Gynecology, Medical University of Vienna, Vienna, Austria.
  • Spanic T; Europa Donna Slovenia, Slovenia, USA.
  • Tolaney SM; Dana-Farber Cancer Institute, Boston, USA.
  • Turner NC; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Curigliano G; Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS and University of Milano, Milan, Italy.
  • Loibl S; GBG Forschungs GmbH, Neu-Isenburg, Germany.
  • Paluch-Shimon S; Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel.
  • Harbeck N; Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.
Ann Oncol ; 32(12): 1475-1495, 2021 12.
Article in En | MEDLINE | ID: mdl-34678411
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Diagnostic_studies / Guideline Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Diagnostic_studies / Guideline Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Italy